cardiff

Draig Therapeutics Launches with $140 Million (107 Million) Total Investment to Advance its Portfolio of Next-Generation Therapies for Major Neuropsychiatric Disorders

Clinical-stage company led by world-class team targeting core neurotransmission pathways underlying neuropsychiatric disorders with a rich pipeline of novel, potentially…

2 weeks ago

Llusern Scientific Announces ISO 13485 Certification for itsPoint-of-Care Diagnostics System for Urinary Tract Infections

June 17, 2025 04:00 ET  | Source: Llusern Scientific CARDIFF, United Kingdom, June 17, 2025 (GLOBE NEWSWIRE) -- Llusern Scientific,…

2 weeks ago